Toggle Offcanvas
...
 
Leuprorelin Tenders

Leuprorelin Tenders

View Leuprorelin tenders, RFPs and contracts. Bid on readily available Leuprorelin tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Leuprorelin tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Leuprorelin.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Leuprorelin market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Leuprorelin tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

67 Live Notices for Leuprorelin Tenders

Showing 1 to 20

Open House Pharmaceutical Dact Treaties To The Active Ingredient Leuprorelin, Atc L02Ae02, H01Ca04
country Germany
posting date19 May 2025
deadline30 Apr 2027
Open House Pharmaceutical Dact Treaties To The Active Ingredient Leuprorelin, Atc L02Ae02, H01Ca04
country Germany
posting date19 May 2025
deadline30 Apr 2027
Open House Pharmaceutical Dact Treaties To The Active Ingredient Leuprorelin, Atc L02Ae02, H01Ca04
country Germany
posting date19 May 2025
deadline30 Apr 2027
Completion Of Non-Exclusive Discount Agreements According To §130A (8) Sgb V On Various Active Ingredient/En/Combinations With Any Final Option Within The Framework Of The So-Called Open House Procedure
country Germany
posting date12 Apr 2025
deadline05 Aug 2026
Acquisition Of Medications
country Dominican Republic
posting date05 Apr 2025
deadline21 May 2025
Medicines Containing The Active Ingredient Leuprorelin (Atc: L02Ae02)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Leuprorelin (Atc: L02Ae02)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Leuprorelin (Atc: L02Ae02)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Leuprorelin (Atc: L02Ae02)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Leuprorelin (Atc: L02Ae02)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Leuprorelin (Atc: L02Ae02)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Leuprorelin (Atc: L02Ae02)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Leuprorelin (Atc: L02Ae02)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Leuprorelin (Atc: L02Ae02)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Leuprorelin (Atc: L02Ae02)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Leuprorelin (Atc: L02Ae02)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Leuprorelin (Atc: L02Ae02)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Leuprorelin (Atc: L02Ae02)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Leuprorelin (Atc: L02Ae02)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Leuprorelin (Atc: L02Ae02)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026

Share Share this page